Transition from open to robotic liver surgery: effects of robotic implementation on outcomes and costs
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Robotic liver surgery (RLS) is increasingly adopted, yet its institutional impact during implementation remains poorly defined. We evaluated the transition from a purely open liver surgery (OLS) program to a hybrid RLS program in a tertiary hepatobiliary center. METHODS: This retrospective single-center cohort study included all consecutive liver resections between 01/2020 and 06/2025. A 2-year OLS phase (phase 1) was compared with a subsequent 2-year RLS implementation phase (phase 2). Primary outcomes included perioperative morbidity, textbook outcome, and costs. A propensity score matched (PSM) analysis was performed to compare outcomes between patients undergoing minor resections of OLS and RLS. RESULTS: A total of 428 patients underwent liver resection (phase 1: 212 and phase 2: 216). Nearly half of liver resections (45%) were performed robotically in phase 2. As the strategy shifted toward parenchyma-sparing resections (23-45%), major liver surgeries decreased (45.8-29.6%). Major complications decreased from 40.6 to 21.8% (p = 0.001), with reductions in reinterventions, reoperations, and 90-day mortality (9.9 vs. 3.3%, p = 0.010). Correspondingly, length of stay decreased from 11 to 7 days (p < 0.001), and textbook outcome improved from 66.0 to 82.4% (p < 0.001). Total costs were significantly reduced despite higher operative costs. In the PSM cohort, RLS was associated with longer operative times (191 vs. 109 min, p < 0.001) yet shorter length of stay (4 vs. 8 days, p < 0.001). CONCLUSION: Implementation of RLS appears associated with improved outcomes and reduced costs, even during the early implementation phase. RLS is prone to become an integral component of modern hepatobiliary programs, complementing rather than replacing traditional OLS.
Source: Surgical Endoscopy
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,390
Funder: Universität Basel
OpenAlex ID: W7236711521
